RabMAb

Anti-KIFAP3抗体[EPR5599] (ab109026)

概述

  • 产品名称Anti-KIFAP3抗体[EPR5599]
    参阅全部 KIFAP3 一抗
  • 描述
    兔单克隆抗体[EPR5599] to KIFAP3
  • 经测试应用适用于: WB, IHC-P, ICCmore details
    不适用于: Flow Cyt or IP
  • 种属反应性
    与反应: Mouse, Rat, Human
  • 免疫原

    Synthetic peptide corresponding to residues at the N-terminus of Human KIFAP3.

  • 阳性对照
    • HeLa, SH-SY5Y, C6, 293T, and Human fetal kidney lysates, Human bladder carcinoma tissue
  • 常规说明

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.

性能

相关产品

应用

Our Abpromise guarantee covers the use of ab109026 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

应用 Ab评论 说明
WB 1/1000 - 1/10000. Detects a band of approximately 100 kDa (predicted molecular weight: 91 kDa).
IHC-P 1/250 - 1/500. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
ICC 1/50 - 1/100.
  • 应用说明Is unsuitable for Flow Cyt or IP.
  • 靶标

    Anti-KIFAP3 antibody [EPR5599] 图像

    • All lanes : Anti-KIFAP3 antibody [EPR5599] (ab109026) at 1/1000 dilution

      Lane 1 : HeLa lysate
      Lane 2 : SH-SY5Y lysate
      Lane 3 : C6 lysate
      Lane 4 : 293T lysate
      Lane 5 : Human fetal kidney lysate

      Lysates/proteins at 10 µg per lane.


      Predicted band size : 91 kDa
    • Immunohistochemical analysis of paraffin-embedded Human bladder carcinoma tissue using ab109026 at a dilution of 1/250.

    Anti-KIFAP3 antibody [EPR5599] (ab109026)参考文献

    ab109026 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab109026.
    Please use the links above to contact us or submit feedback about this product.

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"